Ambrx Biopharma Investor Relations Material
Latest events
Investor Day 2023
Ambrx Biopharma
Q3 2023
13 Nov, 2023
Corporate Presentation
6 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ambrx Biopharma Inc
Access all reports
Ambrx Biopharma Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of antibody drug conjugates (ADCs) and other engineered therapies aimed at modulating the immune system. The company is headquartered in La Jolla, California, and its shares are listed on the Nasdaq.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
AMAM
Country
🇺🇸 United States